國立虎尾科技大學 |

Chronic Lymphocytic Leukemia

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Chronic Lymphocytic Leukemia/ edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
其他作者:	Hallek, Michael.
面頁冊數:	VI, 179 p. 23 illus., 19 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-030-11392-6
ISBN:	9783030113926

Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia[electronic resource] /edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky. - 1st ed. 2019. - VI, 179 p. 23 illus., 19 illus. in color.online resource. - Hematologic Malignancies,2197-9766. - Hematologic Malignancies,.

Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed. .

ISBN: 9783030113926

Standard No.: 10.1007/978-3-030-11392-6doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Chronic Lymphocytic Leukemia
LDR:02610nam a22003975i 4500 001 1014802
003 DE-He213
005 20200702083944.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030113926 $9 978-3-030-11392-6
024 7 $a 10.1007/978-3-030-11392-6 $2 doi
035 $a 978-3-030-11392-6
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Chronic Lymphocytic Leukemia $h [electronic resource] / $c edited by Michael Hallek, Barbara Eichhorst, Daniel Catovsky.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a VI, 179 p. 23 illus., 19 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Hematologic Malignancies, $x 2197-9766
505 0 $a Pathophysiolgoy -- Diagnostics -- Clinical Presentation -- Prognostic Markers -- Treatment -- Follow-up and Complications -- Related Entities.
520 $a This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed. .
650 0 $a Hematology. $3 645254
650 0 $a Oncology . $3 1253469
650 2 4 $a Oncology. $3 593951
700 1 $a Hallek, Michael. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226223
700 1 $a Eichhorst, Barbara. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226224
700 1 $a Catovsky, Daniel. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1226225
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030113919
776 0 8 $i Printed edition: $z 9783030113933
830 0 $a Hematologic Malignancies, $x 2197-9766 $3 1253495
856 4 0 $u https://doi.org/10.1007/978-3-030-11392-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)